You can buy or sell KOOL and other stocks, options, ETFs, and crypto commission-free!
Cesca Therapeutics, Inc. engages in the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine. It operates through the Clinical Development Division and Device Division business segments. Read More The Clinical Development Division segment involves in developing autologous stem cell-based therapeutics that address significant unmet medical needs for applications within the vascular, cardiology, and orthopedic markets. The Device Division segment includes development and commercialization of automated technologies for cell-based therapeutics and bio-processing. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
Rancho Cordova, California
52 Week High
52 Week Low
PR NewswireMar 20
Cesca Therapeutics To Announce Financial Results For The Fourth Quarter Ended December 31, 2018 and Host Conference Call On March 25
RANCHO CORDOVA, Calif., March 20, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2018 on Monday, March 25, 2019 after close of trading. A conference call and webcast will follow at 1:30 p.m. PDT/ 4:30 p.m. EDT. To participate in the conference call, please dial 1-844-889-4331 (dom...
Guru FocusFeb 25
ThermoGenesis Receives Health Canada Approval of its PXP System for Automated Processing of Bone Marrow Cells
RANCHO CORDOVA, Calif., Feb. 25, 2019 /PRNewswire/ -- ThermoGenesis Corp, a private corporation owned by Cesca Therapeutics (Nasdaq: KOOL), and a market leader in automated cellular processing and autologous cell therapies for regenerative medicine, today announced that it received Health Canada approval of its PXP® System for point-of-care harvesting of purified mononuclear cells and platelets from blood or bone marrow. The ThermoGenesis PXP System is a semi-automated, functionally-closed system that harv...
-$0.07 per share
Available Mar 25, After Hours